Skip to content
10-K

Annual Report

QUANTRX BIOMEDICAL CORPORATION

0001654954-21-004257

← back to feed
Filed
Apr 15, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Apr 15, 2021 78.7M sh
Revenue FY 2020 · Dec 31, 2020 $0
Revenue FY 2020 · Dec 31, 2019 $0
Operating Cash Flow FY 2020 · Dec 31, 2019 −$191.67K
Cash And Equivalents FY 2020 · Dec 31, 2019 $130.35K
Cash And Equivalents FY 2020 · Dec 31, 2018 $322.02K
Total Liabilities FY 2020 · Dec 31, 2019 $2.27M
Current Assets FY 2020 · Dec 31, 2019 $137.35K
Total Assets FY 2020 · Dec 31, 2019 $137.35K
Sga Expense FY 2020 · Dec 31, 2019 $59.9K
Net Income FY 2020 · Dec 31, 2019 −$621.92K
Operating Income FY 2020 · Dec 31, 2019 −$201.74K
Stockholders Equity FY 2020 · Dec 31, 2018 −$1.51M